SDHA
SDHA (succinate dehydrogenase complex flavoprotein subunit A, also known as FP, SDHF and SDH2) is the major catalytic flavoprotein subunit of succinate dehydrogenase, or complex II of the mitochondrial respiratory chain. It transfers electrons from succinate to ubiquinone. Browse Assay Genie's current range of SDHA research reagents below, or read on for the biology behind the target.
SDHA is the flavoprotein (Fp) subunit of succinate dehydrogenase (SDH), which forms part of complex II of the mitochondrial electron transport chain. Its central role is to transfer electrons from succinate to ubiquinone (coenzyme Q). SDH also oxidises malate to the non-canonical enol form of oxaloacetate, enol-oxaloacetate. This product is a potent inhibitor of succinate dehydrogenase activity and is subsequently isomerised into keto-oxaloacetate. UniProt additionally notes that SDHA can act as a tumour suppressor.
The SDHA gene encodes a major catalytic subunit of succinate-ubiquinone oxidoreductase. The complex is composed of four nuclear-encoded subunits and sits in the mitochondrial inner membrane, where the SDHA protein is found. SDHA belongs to the FAD-dependent oxidoreductase 2 family, FRD/SDH subfamily, and HGNC places it in the groups for mitochondrial complex II succinate dehydrogenase subunits and flavoproteins. Mouse and rat both carry an ortholog named Sdha, so the target is routinely studied in rodent models.
Mutations in the SDHA gene have been associated with Leigh syndrome, a form of mitochondrial respiratory chain deficiency. NCBI Gene reports a pseudogene on chromosome 3q29 and alternatively spliced transcript variants that encode different isoforms. Earlier gene names include succinate dehydrogenase complex, subunit A, flavoprotein (Fp). Researchers working on SDHA often look at complex II activity, mitochondrial respiration and the link between succinate metabolism and tumour suppression.
SDHA carries electrons from succinate to ubiquinone in complex II, making it a core component for studying the electron transport chain.
Mutations in SDHA have been associated with Leigh syndrome, a mitochondrial respiratory chain deficiency.
UniProt records that SDHA can act as a tumour suppressor, which links this complex II subunit to cancer research.
SDH oxidises malate to enol-oxaloacetate, a potent inhibitor of its own activity, which makes it useful for studying regulation of the enzyme.
SDHA is the flavoprotein subunit of succinate dehydrogenase, part of complex II in the mitochondrial electron transport chain. It transfers electrons from succinate to ubiquinone. SDH also oxidises malate to enol-oxaloacetate, a potent inhibitor of its activity that is then isomerised to keto-oxaloacetate.
SDHA is also known as FP, SDHF and SDH2. Earlier names include succinate dehydrogenase complex, subunit A, flavoprotein (Fp). NCBI Gene reports alternatively spliced transcript variants encoding different isoforms, plus a pseudogene on chromosome 3q29.
Mouse and rat each have an ortholog called Sdha; check the datasheet of any product for its validated reactivity. Mutations in human SDHA have been associated with Leigh syndrome, a mitochondrial respiratory chain deficiency, and UniProt notes it can act as a tumour suppressor.
Other succinate dehydrogenase subunits and respiratory chain components with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P31040; product specifications from Assay Genie datasheets.